US Stock MarketDetailed Quotes

Matinas BioPharma (MTNB)

Watchlist
  • 0.7000
  • -0.0100-1.41%
Close Jan 15 15:55 ET
4.48MMarket Cap-0.20P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Matinas BioPharma (MTNB) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
-65.62%1.1M
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
-65.62%1.1M
--0
Cost of revenue
Gross profit
Operating expense
-64.00%1.58M
-68.54%1.84M
-67.03%1.95M
-18.90%20.16M
-31.41%4.04M
-28.58%4.38M
-5.20%5.84M
-11.67%5.9M
-10.50%24.86M
-10.03%5.89M
Selling and administrative expenses
-26.38%1.58M
-25.57%1.84M
-24.23%1.86M
-15.85%8.73M
-25.20%1.66M
-24.55%2.14M
-5.08%2.47M
-9.44%2.46M
-6.55%10.37M
-16.97%2.22M
-General and administrative expense
-26.38%1.58M
-25.57%1.84M
-24.23%1.86M
-15.85%8.73M
-25.20%1.66M
-24.55%2.14M
-5.08%2.47M
-9.44%2.46M
-6.55%10.37M
-16.97%2.22M
Research and development costs
--0
--0
-97.53%85K
-21.09%11.43M
-35.17%2.38M
-32.05%2.24M
-5.28%3.37M
-13.20%3.45M
-13.13%14.49M
-5.22%3.67M
Operating profit
64.00%-1.58M
68.54%-1.84M
67.03%-1.95M
15.16%-20.16M
31.41%-4.04M
28.58%-4.38M
5.20%-5.84M
-5.66%-5.9M
3.35%-23.77M
-7.43%-5.89M
Net non-operating interest income expense
Other net income (expense)
-57.55%45K
-2,940.00%-3.41M
271.79%290K
-605.95%-4.17M
-880.98%-4.48M
34.18%106K
21.21%120K
6.85%78K
-77.07%824K
-68.96%573K
Gain on sale of security
----
---3.46M
--294K
----
----
----
----
----
----
----
Special income (charges)
--0
--110K
----
-1,015.50%-4.43M
---4.43M
--0
--0
----
-86.14%484K
----
-Less:Impairment of capital assets
----
----
----
--4.43M
----
----
----
----
--0
----
-Gain on sale of business
----
----
----
--0
----
----
----
----
-86.14%484K
----
-Gain on sale of property,plant,equipment
--0
--110K
----
----
----
--0
--0
----
----
----
Other non- operating income (expenses)
-57.55%45K
-152.50%-63K
-105.13%-4K
-22.94%262K
-149.44%-44K
34.18%106K
21.21%120K
6.85%78K
233.33%340K
0.00%89K
Income before tax
64.16%-1.53M
8.29%-5.25M
71.57%-1.66M
-6.05%-24.33M
-60.20%-8.51M
29.40%-4.28M
5.63%-5.72M
-5.64%-5.82M
-9.26%-22.94M
-46.23%-5.31M
Income tax
-80K
0
Net income
64.16%-1.53M
8.29%-5.25M
71.57%-1.66M
-5.71%-24.25M
-58.69%-8.43M
29.40%-4.28M
5.63%-5.72M
-5.64%-5.82M
-9.26%-22.94M
-46.23%-5.31M
Net income continuous Operations
64.16%-1.53M
8.29%-5.25M
71.57%-1.66M
-5.71%-24.25M
-58.69%-8.43M
29.40%-4.28M
5.63%-5.72M
-5.64%-5.82M
-9.26%-22.94M
-46.23%-5.31M
Minority interest income
Net income attributable to the parent company
64.16%-1.53M
8.29%-5.25M
71.57%-1.66M
-5.71%-24.25M
-58.69%-8.43M
29.40%-4.28M
5.63%-5.72M
-5.64%-5.82M
-9.26%-22.94M
-46.23%-5.31M
Preferred stock dividends
Other preferred stock dividends
618K
Net income attributable to common stockholders
49.71%-2.15M
8.29%-5.25M
71.57%-1.66M
-5.71%-24.25M
-58.69%-8.43M
29.40%-4.28M
5.63%-5.72M
-5.64%-5.82M
-9.26%-22.94M
-46.23%-5.31M
Basic earnings per share
52.94%-0.4
10.43%-1.03
75.37%-0.33
5.68%-4.98
-37.70%-1.68
38.85%-0.85
23.33%-1.15
10.67%-1.34
-5.60%-5.28
-22.00%-1.22
Diluted earnings per share
52.94%-0.4
10.43%-1.03
75.37%-0.33
5.68%-4.98
-37.70%-1.68
38.85%-0.85
23.33%-1.15
10.67%-1.34
-5.60%-5.28
-22.00%-1.22
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 00000000-65.62%1.1M0
Operating revenue --0--0--0--0--0--0--0--0-65.62%1.1M--0
Cost of revenue
Gross profit
Operating expense -64.00%1.58M-68.54%1.84M-67.03%1.95M-18.90%20.16M-31.41%4.04M-28.58%4.38M-5.20%5.84M-11.67%5.9M-10.50%24.86M-10.03%5.89M
Selling and administrative expenses -26.38%1.58M-25.57%1.84M-24.23%1.86M-15.85%8.73M-25.20%1.66M-24.55%2.14M-5.08%2.47M-9.44%2.46M-6.55%10.37M-16.97%2.22M
-General and administrative expense -26.38%1.58M-25.57%1.84M-24.23%1.86M-15.85%8.73M-25.20%1.66M-24.55%2.14M-5.08%2.47M-9.44%2.46M-6.55%10.37M-16.97%2.22M
Research and development costs --0--0-97.53%85K-21.09%11.43M-35.17%2.38M-32.05%2.24M-5.28%3.37M-13.20%3.45M-13.13%14.49M-5.22%3.67M
Operating profit 64.00%-1.58M68.54%-1.84M67.03%-1.95M15.16%-20.16M31.41%-4.04M28.58%-4.38M5.20%-5.84M-5.66%-5.9M3.35%-23.77M-7.43%-5.89M
Net non-operating interest income expense
Other net income (expense) -57.55%45K-2,940.00%-3.41M271.79%290K-605.95%-4.17M-880.98%-4.48M34.18%106K21.21%120K6.85%78K-77.07%824K-68.96%573K
Gain on sale of security -------3.46M--294K----------------------------
Special income (charges) --0--110K-----1,015.50%-4.43M---4.43M--0--0-----86.14%484K----
-Less:Impairment of capital assets --------------4.43M------------------0----
-Gain on sale of business --------------0-----------------86.14%484K----
-Gain on sale of property,plant,equipment --0--110K--------------0--0------------
Other non- operating income (expenses) -57.55%45K-152.50%-63K-105.13%-4K-22.94%262K-149.44%-44K34.18%106K21.21%120K6.85%78K233.33%340K0.00%89K
Income before tax 64.16%-1.53M8.29%-5.25M71.57%-1.66M-6.05%-24.33M-60.20%-8.51M29.40%-4.28M5.63%-5.72M-5.64%-5.82M-9.26%-22.94M-46.23%-5.31M
Income tax -80K0
Net income 64.16%-1.53M8.29%-5.25M71.57%-1.66M-5.71%-24.25M-58.69%-8.43M29.40%-4.28M5.63%-5.72M-5.64%-5.82M-9.26%-22.94M-46.23%-5.31M
Net income continuous Operations 64.16%-1.53M8.29%-5.25M71.57%-1.66M-5.71%-24.25M-58.69%-8.43M29.40%-4.28M5.63%-5.72M-5.64%-5.82M-9.26%-22.94M-46.23%-5.31M
Minority interest income
Net income attributable to the parent company 64.16%-1.53M8.29%-5.25M71.57%-1.66M-5.71%-24.25M-58.69%-8.43M29.40%-4.28M5.63%-5.72M-5.64%-5.82M-9.26%-22.94M-46.23%-5.31M
Preferred stock dividends
Other preferred stock dividends 618K
Net income attributable to common stockholders 49.71%-2.15M8.29%-5.25M71.57%-1.66M-5.71%-24.25M-58.69%-8.43M29.40%-4.28M5.63%-5.72M-5.64%-5.82M-9.26%-22.94M-46.23%-5.31M
Basic earnings per share 52.94%-0.410.43%-1.0375.37%-0.335.68%-4.98-37.70%-1.6838.85%-0.8523.33%-1.1510.67%-1.34-5.60%-5.28-22.00%-1.22
Diluted earnings per share 52.94%-0.410.43%-1.0375.37%-0.335.68%-4.98-37.70%-1.6838.85%-0.8523.33%-1.1510.67%-1.34-5.60%-5.28-22.00%-1.22
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -